Gts Securities LLC Ionis Pharmaceuticals Inc Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$40.06 - $51.86 $1.98 Million - $2.56 Million	-49,400 Reduced 80.46%	12,000 $480,000
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $1.79 Million - $2.35 Million	49,200 Added 403.28%	61,400 $2.93 Million
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $42,030 - $53,550	-1,000 Reduced 7.58%	12,200 $528,000
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $481,629 - $573,093	-11,100 Reduced 45.68%	13,200 $667,000
Q3 2023 Nov 15, 2023	BUY	$38.5 - $47.13 $935,550 - $1.15 Million	24,300 New	24,300 $1.1 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.87B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.